We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.37 | -0.92% | 39.64 | 40.005 | 39.49 | 39.97 | 4,916,964 | 01:00:00 |
From Jul 2019 to Jul 2024
By Carlo Martuscelli
GlaxoSmithKline PLC (GSK.LN) said Friday that it was pleased to note that the U.K.'s fraud watchdog closed its investigation into the company without requiring any further action.
The Serious Fraud Office's case dates back to May 2014, when it began to investigate the FTSE 100-listed drugmaker over bribery charges in China. A court in the Asian country found one of Glaxo's local subsidiaries guilty of bribery, and fined the company $491.5 million in September 2014.
Earlier in the month Glaxo had said that the SFO had requested more information on its use of third-party advisers.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com
(END) Dow Jones Newswires
February 22, 2019 06:52 ET (11:52 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
